Investors Asset Management of Georgia’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $223K | Buy |
+1,032
| New | +$197K | 0.08% | 178 |
|
|
2024
Q4 | – | Sell |
-1,032
| Closed | -$200K | – | 163 |
|
|
2024
Q3 | $200K | Hold |
1,032
| – | – | 0.09% | 156 |
|
|
2024
Q2 | $239K | Hold |
1,032
| – | – | 0.12% | 138 |
|
|
2024
Q1 | $223K | Hold |
1,032
| – | – | 0.1% | 142 |
|
|
2023
Q4 | $267K | Hold |
1,032
| – | – | 0.14% | 131 |
|
|
2023
Q3 | $259K | Hold |
1,032
| – | – | 0.14% | 130 |
|
|
2023
Q2 | $294K | Hold |
1,032
| – | – | 0.15% | 127 |
|
|
2023
Q1 | $287K | Sell |
1,032
-200
| -16% | -$55.3K | 0.15% | 129 |
|
|
2022
Q4 | $341K | Hold |
1,232
| – | – | 0.18% | 117 |
|
|
2022
Q3 | $329K | Hold |
1,232
| – | – | 0.17% | 120 |
|
|
2022
Q2 | $251K | Hold |
1,232
| – | – | 0.13% | 140 |
|
|
2022
Q1 | $259K | Hold |
1,232
| – | – | 0.13% | 148 |
|
|
2021
Q4 | $296K | Hold |
1,232
| – | – | 0.14% | 139 |
|
|
2021
Q3 | $349K | Hold |
1,232
| – | – | 0.18% | 120 |
|
|
2021
Q2 | $427K | Hold |
1,232
| – | – | 0.23% | 103 |
|
|
2021
Q1 | $345K | Hold |
1,232
| – | – | 0.2% | 114 |
|
|
2020
Q4 | $302K | Hold |
1,232
| – | – | 0.2% | 106 |
|
|
2020
Q3 | $349K | Hold |
1,232
| – | – | 0.23% | 92 |
|
|
2020
Q2 | $330K | Hold |
1,232
| – | – | 0.23% | 96 |
|
|
2020
Q1 | $390K | Hold |
1,232
| – | – | 0.32% | 67 |
|
|
2019
Q4 | $366K | Hold |
1,232
| – | – | 0.22% | 102 |
|
|
2019
Q3 | $287K | Hold |
1,232
| – | – | 0.18% | 116 |
|
|
2019
Q2 | $288K | Hold |
1,232
| – | – | 0.19% | 115 |
|
|
2019
Q1 | $291K | Hold |
1,232
| – | – | 0.2% | 113 |
|
|
2018
Q4 | $371K | Hold |
1,232
| – | – | 0.3% | 86 |
|
|
2018
Q3 | $435K | Hold |
1,232
| – | – | 0.3% | 83 |
|
|
2018
Q2 | $358K | Hold |
1,232
| – | – | 0.26% | 101 |
|
|
2018
Q1 | $337K | Hold |
1,232
| – | – | 0.25% | 105 |
|
|
2017
Q4 | $392K | Hold |
1,232
| – | – | 0.28% | 91 |
|
|
2017
Q3 | $386K | Hold |
1,232
| – | – | 0.28% | 91 |
|
|
2017
Q2 | $334K | Hold |
1,232
| – | – | 0.23% | 99 |
|
|
2017
Q1 | $337K | Hold |
1,232
| – | – | 0.23% | 97 |
|
|
2016
Q4 | $349K | Hold |
1,232
| – | – | 0.26% | 92 |
|
|
2016
Q3 | $386K | Hold |
1,232
| – | – | 0.29% | 77 |
|
|
2016
Q2 | $298K | Hold |
1,232
| – | – | 0.23% | 99 |
|
|
2016
Q1 | $321K | Hold |
1,232
| – | – | 0.27% | 92 |
|
|
2015
Q4 | $377K | Hold |
1,232
| – | – | 0.32% | 73 |
|
|
2015
Q3 | $360K | Hold |
1,232
| – | – | 0.32% | 72 |
|
|
2015
Q2 | $498K | Hold |
1,232
| – | – | 0.43% | 57 |
|
|
2015
Q1 | $520K | Hold |
1,232
| – | – | 0.43% | 58 |
|
|
2014
Q4 | $418K | Buy |
+1,232
| New | +$399K | 0.36% | 68 |
|
Other funds holding BIIB
Investors Asset Management of Georgia's BIIB Position: Q2 2026 in Review
Investors Asset Management of Georgia opened a new position in Biogen (BIIB) in Q2 2026: 1,032 shares worth $223K. The stake represents 0.08% of the portfolio and ranks #178 among its holdings. This is a return to the name: Investors Asset Management of Georgia previously reported a position in BIIB as recently as Q3 2024.
Investors Asset Management of Georgia first reported a position in BIIB in Q4 2014 and has held it in 41 quarters since. The position peaked at $520K in Q1 2015. 746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Investors Asset Management of Georgia held 1,032 shares of Biogen worth $223K as of Q2 2026.
- Biogen was a new Investors Asset Management of Georgia position in Q2 2026.
- Biogen made up 0.08% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #178 holding.
- Investors Asset Management of Georgia first reported a position in Biogen in Q4 2014 and has held it in 41 quarters since.
- Investors Asset Management of Georgia's Biogen position peaked at $520K in Q1 2015.
- 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.